Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06468878
Other study ID # 7179E
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date May 2025

Study information

Verified date June 2024
Source Boston University Charles River Campus
Contact Laura J Long, PhD
Phone 617-358-4303
Email ljlong@bu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Exposure-based cognitive behavior therapy is an efficacious treatment for acrophobia (fear of heights) and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate the effects of liked, non-lyrical background music on the efficacy of a brief VR exposure intervention.


Description:

The goal of this clinical trial is to compare acrophobia (fear of heights) outcomes for VR exposure therapy in college students with elevated acrophobia when listening to music during exposure versus no music. The overarching aim of the current study is to determine how liked, non-lyrical background music will influence acrophobia outcomes after a brief exposure therapy session in VR. The study involves three phases: (1) initial screening, (2) in-person assessment and a brief exposure intervention for a subset of participants with elevated acrophobia, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on an acrophobia scale will be assigned to an experimental or control condition prior to undergoing VR based exposure therapy. Acrophobia outcomes are measured immediately post-intervention and one week later. Researchers will compare participants in the music condition to participants in the non-music condition to see if acrophobia outcomes differ.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 44
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Self-report of 18 years of age or older - Current student at Boston University - Ability to read English to provide informed consent - Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet) - For Phase 2: Acrophobia score of = 45.45 on the Acrophobia Questionnaire (AQ) Anxiety Subscale Exclusion Criteria: - Previous participation (i.e. no participant may take the survey more than once).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exposure Intervention Plus Music Induction
VR exposure for acrophobia with background music.
Exposure Intervention With No Music Induction
VR exposure for acrophobia with no background music.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Boston University Charles River Campus

Outcome

Type Measure Description Time frame Safety issue
Primary Acrophobia (Fear of Heights) Assessed using the Acrophobia Questionnaire (AQ) Anxiety Subscale Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
Secondary Valance Self-report measure of how participant feels about experiencing high-height environments. Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
Secondary Height-Relevant Interpretations Assessed using the Heights Interpretation Questionnaire (HIQ) Comparison of pre-exposure scores to scores from the follow-up survey one week after exposure
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02584387 - 3D Video Virtual Reality Exposure Therapy Study N/A
Completed NCT03387254 - Virtual Reality and Brain Stimulation, an Experiential Approach N/A
Completed NCT04737915 - Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights N/A
Completed NCT04975854 - Virtual Reality Exposure Therapy for Acrophobia N/A
Completed NCT04620447 - Intelligent Virtual Reality Therapy System and Testing Its Clinical Efficacy Phase 1/Phase 2
Completed NCT05841329 - Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia N/A
Completed NCT05780203 - CBM in the Context of Exposure for Acrophobia N/A
Suspended NCT03917433 - Augmenting Virtual Reality Exposure Therapy for Acrophobia N/A
Not yet recruiting NCT03893214 - Single Session Virtual Reality Therapy in Acrophobia - and the Role of Respiration N/A